Touch to read more.
Buy-side Advice
Acquisition of 100% shares
Target company
2023 - USA
Transaction advisory to RQM+, a portfolio company of Linden Capital Partners, on its acquisition of Libra Medical
MoreBuy-side Advice
Strategic advisory
Target company
2023 - USA
Advisory to Frontier Dental Laboratories, a portfolio company of O2 Investment Partners, on its partnership with Friendship Dental Laboratories
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - Poland
M&A advisory to owners of Klinika Bocian – the leading centers providing infertility treatment, gynecology and obstetrics services in Poland – in the process of purchase of...
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - United Kingdom
Translink advised Peak Proteins of the 100% sale to Sygnature Discovery
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - France
Capital advisory to Prolaser - a European leader in the alternative printing consumables market, in the process of acquisition of SARL Fournisseur Matériel Médical.
MoreSell-side Advice
Sale of 100 % shares
Investor
2022 - UK
Capital advisory to SurePharm predominantly serving the pharmaceutical market in the sale process of company
MoreSell-side Advice
Sale of 100 % shares
Investor
2022 - Denmark
Capital advisory to Hegenberger Speculum in the sale process of company
MoreSell-side Advice
Acquisition of several legal entities
Investor
2021 - Germany